The association between tick-borne infections, Lyme borreliosis and autism spectrum disorders

Medical Hypotheses

Volumn 70, Issue 5, 2008, Pages 967-974

  Bransfield, Robert C ^a   Wulfman, Jeffrey S ^b   Harvey, William T ^c   Usman, Anju I ^d  

^a Riverview Medical Center   (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^c Rocky Mountain Chronic Disease Specialists   (United States)

^d True Health Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMATE RECEPTOR; KYNURENIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; QUINOLINIC ACID;

ARTICLE; AUTISM; BORRELIA BURGDORFERI; DISEASE ASSOCIATION; GEOGRAPHIC DISTRIBUTION; HUMAN; IMMUNOREACTIVITY; KLUVER BUCY SYNDROME; LABORATORY TEST; LYME DISEASE; NEUROIMAGING; NEUROLOGIC DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; TEMPORAL LOBE; TICK BORNE DISEASE;

ANIMALS; AUTISTIC DISORDER; FEMALE; HUMANS; IMMUNE SYSTEM; LYME DISEASE; MALE; MODELS, BIOLOGICAL; MODELS, THEORETICAL; NERVE NET; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SYNDROME; TICK-BORNE DISEASES;

BORRELIA BURGDORFERI; IXODIDA; MYCOPLASMA;

EID: 40849139801     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2007.09.006     Document Type: Article

References (71)

1. CDC Incidence of LYD: Reported LYD cases by state, 1993-2005: Incidence 2005.
2. US Dept Edu, Office of Spec Educ Progr, DANS, OMB# 18200043. "Children with Disabilities Receiving Special Ed Under Part B of the IDEA", 2005.
3. Personal communication with J Burrascano.
4. Posey D.J., Kem D.L., Swiezy N.B., Sweeten T.L., Wiegand R.E., and McDougle C. Pilot study of d-cycloserine in subjects with autistic disorder. Am J Psychiat 161 11 (2004) 2115-2117
5. Sandler R.H., Finegold S.M., Bolte E.R., et al. Short-term benefit from oral vancomycin treatment of regressive-onset autism. J Child Neurol 15 7 (2000) 429-435
6. Kugathasan S. Pediatric inflammatory bowel disease: clinical and therapeutic aspects. Curr Opin Gastroenterol 17 4 (2001) 350-355
7. Zaidi A.S., and Singer C. Gastrointestinal and hepatic manifestations of tick-borne diseases in the United States. Clinical Infect Dis 34 (2002) 1206-1212
8. Fried M.D., Abel M., Pietrucha D., Kuo Y.H., and Bal A. The spectrum of gastrointestinal manifestations in children and adolescents with LYD. JSTD 6 (1999)
9. Fried M. GI manifestations of LYD. 14th Int Sc Conf LYD and Other TBD. 2001.
10. Gardner T. Lyme disease. Infec Dis Fetus and Newborn Infant (2000), Saunders
11. Jones C.R., Smith H., Gibb E., and Johnson L. Gestational Lyme Disease Case studies of 102 Live Births. Lyme Times (2005) 34-36 Summer
12. Harvey W.T., and Salvato P. 'Lyme disease': ancient engine of an unrecognized Borreliosis pandemic?. Med Hypotheses 60 5 (2003) 742-759
13. Bach G. Sexual Transmission of Lyme Disease. Microbes and Mental Illness Symp (2000), Am Psych Assn Inst Psych Services
14. Jones CR. Lyme Disease and Autism. LIA Conf 2007.
15. Schmidt B.L., Aberer E., Stockenhuber C., Klade H., Breier F., and Luger A. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in the urine and breast milk of patients with Lyme Borreliosis. Diagn Microbiol Infect Dis 21 3 (1995) 121-128
16. Vojdani A. Immunology of Lyme disease and associated disorders. LIA Conf (2007)
17. Duncan T. Informal Lyme-autism study: a preliminary report. LIA Conf (2007)
18. Nicolson G.L., Gan R., Nicolson N.L., and Haier J. Evidence for Mycoplasma, Chlamydia pneunomiae and HHV-6 Co-infections in the blood of patients with ASD. J Neurosci Res 85 (2007) 1143-1148
19. Nicholson G.L. Systemic intracellular bacterial infections in neurodegenerative (MS, ALS) and behavioral disorders (ASD). Infect Dis Newslett (2007)
20. Pancewicz S.A., Skrzydlewska E., Hermanowska-Szpakowicz T., Stankiewicz A., and Kondrusik M. Evaluation of oxidoreductive potential of patients with neuroborreliosis. Przegl Epidemiol 56 3 (2002) 425-433
21. Chauhan A., and Chauhan V. Oxidative stress in autism. Pathophysiology 13 3 (2006) 171-181
22. James S.J., Cutler P., Melnyk S., Jernigan S., Janak L., Gaylor D.W., et al. Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutr 80 6 (2004) 1611-1617
23. Herbert M.R., Ziegler D.A., Deutsch C.K., et al. Dissociations of cerebral cortex, subcort and cerebral white matter volumes in autistic boys. Brain 126 5 (2003) 1182-1192
24. Nacewicz B.M., Dalton K.M., Johnstone T., et al. Amygdala volume and nonverbal social impairment in adolescent and adult males with autism. Arch Gen Psychiat 63 12 (2006) 1417-1428
25. DeLong G.R., Bean S.C., and Brown III F.R. Acquired reversible autistic syndrome in acute encephalopathic illness in children. Arch Neurol 38 3 (1981) 191-194
26. Newberg A., Hassan A., and Alavi A. Cerebral metabolic changes associated with Lyme disease. Nucl Med Commun 23 8 (2002) 773-777
27. Fallon B.A., Keilp J., Prohovnik I., Heertum R.V., and Mann J.J. Regional cerebral blood flow and cognitive deficits in chronic LYD. J Neuropsych Clin Neurosci 15 3 (2003) 326-332
28. Barnea-Goraly N., Kwon H., Menon V., Eliez S., Lotspeich L., and Reiss A.L. White matter structure. Biol Psychiat 55 3 (2004) 323-326
29. Moeller JR. Functional Neuroimaging findings in Chronic LYD; research as a tool to solve medical controversies. Lyme and TBD research cen Columbia Univ 2007.
30. Mc Ewen B.S. Mood disorders and allostatic load. Biol Psychiat 54 3 (2003) 200-207
31. Schapira A.H., and Olanow C.W. Neuroprotection in Parkinson disease: mysteries, myths, and misconceptions. JAMA 291 (2004) 358-364
32. Baron-Cohen S., Ring H.A., Bullmore E.T., Wheelwright S., Ashwin C., and Williams S.C. The amygdala theory of autism. Neurosci Biobehav Rev 24 3 (2000) 355-364
33. Libbey J.E., Sweeten T.L., McMahon W.M., and Fujinami R.S. Autistic disorder and viral infections. J Neurovirol 11 1 (2005) 1-10
34. Auvichayapat N., Auvichayapat P., Watanatorn J., Thamaroj J., and Jitpimolmard S. Kluver-Bucy syndrome after mycoplasmal bronchitis. Epilepsy Behav 8 1 (2005) 320-322
35. Boorom K.F. Is this recently characterized GI pathogen responsible for rising rates of IBD associated autism in Europe and the US?. Med Hypotheses 69 3 (2007) 652-659
36. Meyer U., Yee B.K., and Feldon J. The neurodevelopmental impact of prenatal infections at different times of pregnancy: the earlier the worse?. Neuroscientist 13 3 (2007) 241-256
37. Rice D., and Barone S. Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ Health Perspect 108 3 (2000) 511-533
38. Younger D. Small nerve fiber disruption in OspA vaccine recipients. Am Acad Neurol. Meeting 2007.
39. Labuda M., and Nuttall P.A. Tick-borne viruses. Parasitology 129 Suppl (2004) S221-S245
40. Hansen S.K., Rainey P.B., Haagensen J.A., and Molin S. Evolution of species interactions in a biofilm community. Nature 445 (2007) 533-536
41. Diterich I., et al. Borrelia burgdorferi-induced tolerance as a model of persistence via immunosuppression. Infect Immun 71 7 (2003) 3979-3987
42. Purvis A.C. Immunodepression in B. microti infections. Parasitology 75 2 (1977) 197
43. Kyckova K., and Kopecky J. Effect of tick saliva on mechanisms of innate immune response against Borrelia afzelii. J Med Entomol 43 6 (2006) 1208-1214
44. Fallon B.A., and Nields J.A. Lyme disease: a neuropsychiatric illness. Am J Psychiat 151 11 (1994) 1571-1583
45. MacDonald A. Borrelia Attack Models. New Haven Lyme Conf 2007.
46. Livengood J.A., and Gilmore R.D. Invasion of human neuronal and glial cells by an infectious strain of Borrelia burgdorferi. Microbes Infect 8 14-15 (2006) 2832-2840
47. Kisand K.E., Prukk T., Kisand K.V., Luus S., Kalbe I., and Uibo R. Propensity to excessive proinflammatory response in chronic Lyme borreliosis. APMIS 115 2 (2007) 134-141
48. Oksi J, Kalimo H, Marttila RJ, Marjamäki M, Sonninen P, Nikoskelainen J, et al. Inflammatory brain changes in Lyme borreliosis 1996;119(6):2143-54.
49. Halperin J.J., and Heyes M.P. Neuroactive kynurenines in LB. Neurology 42 1 (1992) 43-50
50. Stone T.W., Mackay G.M., Forrest C.M., Clark C.J., and Darlington L.G. Tryptophan metabolites and brain disorders. Clin Chem Lab Med 41 7 (2003) 852-859
51. Salmond C.H., Ashburner J., Connelly A., Friston K.J., Gadian D.G., and Vargha-Khadem F. The role of the medial temporal lobe in ASD. Eur J Neurosci 22 3 (2005) 764-772
52. Yamada K., Fuji K., Nabeshima T., and Kameyama T. Neurotoxicity by continuous infusion of quinolinic acid into the lateral ventricle in rats. Neuroscience 118 1 (1990) 128-131
53. Fatemi S.H., Halt A.R., Stary J.M., Kanodia R., Schulz S.C., and Realmuto G.R. Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in autistic parietal and cerebellar cortices. Biol Psychiat 52 8 (2002) 805-810
54. McFarland R., Blokhin A., Sydnor J., Mariani J., and Vogel M.W. Oxidative stress, nitric oxide, and cell death in Lurcher Purkinje cells. Dev Neurobiol 67 8 (2007) 1032-1046
55. Yip J., Soghomonian J.J., and Blatt G.J. Decreased GAD67 mRNA levels in cerebellar Purkinje cells in autism. Acta Neuropathol (Berl) 113 5 (2007) 559-568
56. Wilner A.N. Elevated TNF found in CSF of autistic children. CNS News 9 (2007) 4
57. Patterson P. International neuroscience conference. 2007. Melbourne 〈http://www.news.com.au/story/0,23599,22079407-2,00.html?from=public_rss〉 [accessed 08.03.07].
58. Cohly H.H., and Panja A. Immunological findings in autism. Int Rev Neurobiol 71 (2005) 317-341
59. Vargas D.L., Nascimbene C., Krishnan C., Zimmerman A.W., and Pardo C.A. Neuroglial activation and neuroinflammation in the brain with autism. Ann Neurol 57 1 (2005) 67
60. Rasley A., Anguita J., and Marriott I. Borrelia burgdorferi induces inflammatory mediator production by murine microglia. J Neuroimmunol 130 1-2 (2002) 22-31
61. Alaedini A., and Latov N. Antibodies against OspA epitopes of Borrelia burgdorferi cross-react with neural tissue. J Neuroimmunol 159 (2005) 192-195
62. MacDonald A.B. Spirochetal cyst forms in neurodegenerative disorders, ... hiding in plain sight. Med Hypotheses 67 4 (2006) 819-832
63. Lee L.C., Zachary A.A., Leffell M.S., Newschaffer C.J., Matteson K.J., Tyler J.D., et al. HLA-DR4 in families with autism. Pediatr Neurol 35 5 (2006) 303-307
64. Steere A.C., Klitz W., Drouin E.E., et al. Antibiotic-refractory Lyme arthritis is associated with HLA-DR molecules that bind a Bb peptide. J Exp Med 203 4 (2006) 961
65. Nicholson G. The Role of Chronic Intracellular Infections in ASD. LIA Conf 2007.
66. Rawadi G., Roman-Roman S., et al. Effects of Mycoplasma fermentans on the Myelomonocytic lineage: different molecular entities with cytokine-inducing and cytocidal potential. J Immunol 156 2 (1996) 670-678
67. Latov N., Wu A.T., Chin R.L., Sander H.W., Alaedini A., and Brannagan III T.H. Neuropathy and cognitive impairment following vaccination with the OspA protein of Borrelia burgdorferi. J Peripher Nerv Syst 9 3 (2004) 165-167
68. Scott DW. Mycoplasm: The linking pathogen in neurosystemic dis. Nexus 2001;8.
69. Perry V.H., Cunningham C., and Holmes C. Systemic infections and inflammation affect chronic neurodegeneration. Nat Rev Immunol 7 2 (2007) 161-167
70. Kern J.K., and Jones A.M. Evidence of toxicity, oxidative stress, and neuronal insult in autism. J Toxicol Environ Health B Crit Rev 9 6 (2006) 485-499
71. Autism Has High Costs to US Society. Harvard School Public Health. 4-25-06 〈http://www.hsph.harvard.edu/news/press-releases/2006-releases/press04252006.html〉 [accessed 08.05.07].